Palo Alto, CA, United States of America

Aldrich N K Lau

USPTO Granted Patents = 37 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 215(Granted Patents)


Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
37 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Aldrich N K Lau in Oligonucleotide Synthesis

Introduction

Aldrich N K Lau is a prominent inventor based in Palo Alto, CA, with an impressive portfolio of 37 patents. His work primarily focuses on the development of compounds and methods that enhance liquid phase oligonucleotide synthesis, significantly contributing to advancements in biotechnology and therapeutic applications.

Latest Patents

Among his latest patents, Lau has developed innovative methods for liquid phase oligonucleotide synthesis. One notable patent describes the use of small molecules with lipophilic groups to improve this synthesis method. Additionally, he has made significant contributions with his patent on functionalized N-acetylgalactosamine analogs, which details methods of preparation and potential uses for targeted delivery in oligonucleotide-based therapeutics.

Career Highlights

Aldrich Lau has held pivotal roles in notable companies such as Applied Biosystems, LLC and Hongene Biotech Corporation. His expertise in oligonucleotide synthesis and functionalization has placed him at the forefront of research and innovation within the biotech sector. His contributions to both academic and industrial research have made profound impacts on the development of new therapeutic agents.

Collaborations

Throughout his career, Lau has collaborated with distinguished colleagues, including David Yu and Yun-Chiao Yao, to drive forward research initiatives that aim to improve oligonucleotide synthesis and application. These partnerships have facilitated the sharing of knowledge and technology, elevating the research output and enhancing the impact of their innovations.

Conclusion

Aldrich N K Lau's advancements in chemical compounds and synthesis techniques have made him a key figure in the field of biotechnology. His dedication to innovation and collaboration continues to inspire new developments in oligonucleotide-based therapeutics, marking his influence on future scientific discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…